A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is application/pdf
.
No Perinatal HIV-1 Transmission From Women With Effective Antiretroviral Therapy Starting Before Conception
2015
Clinical Infectious Diseases
Background. The efficacy of preventing perinatal transmission (PT) of human immunodeficiency virus type 1 (HIV-1) depends on both viral load (VL) and treatment duration. The objective of this study was to determine whether initiating highly active antiretroviral therapy (ART) before conception has the potential to eliminate PT. Methods. A total of 8075 HIV-infected mother/infant pairs included from 2000 to 2011 in the national prospective multicenter French Perinatal Cohort (ANRS-EPF) received
doi:10.1093/cid/civ578
pmid:26197844
fatcat:4h4dcsc5tzb7dk7t6phrgndt2e